Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideJNJJohnson & Johnson
FinDog View：Bullish
| Metric | JNJ | MRNA |
|---|
| Close | 273.20 | 221.72 |
| Market Cap | $666B | $88.3B |
| 1M | +3.20% | +15.14% |
| P/E (TTM) | 41.3 | — |
| Forward P/E | 22.0 | — |
| P/E 5-Yr Percentile | 100 | — |
| P/S | 6.7 | 39.7 |
| P/B | 7.8 | 13.1 |
| Dividend Yield | 3.12% | — |
| Latest Quarter Revenue | $25.4B | $145M |
| Revenue YoY | +5.9% | +2.1% |
| Gross Margin | 68.1% | 35.9% |
| Latest Quarter EPS | 0.09 | -1.97 |
| Avg Post-Earnings Move | ±0.6% | ±4.2% |
| EPS Beat Rate | 1 / 1 | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 1.18% | — |
| 90-Day Net Insider Buying | −$62.0M | −$62.6M |
JNJ · Revenue, Last 8 Quarters ($B)
MRNA · Revenue, Last 8 Quarters ($B)
